Blog Archives

Great Lakes NeuroTechnologies Wins Patent on Using Cell Phones and Smart Watches to Help Treat Parkinson’s Disease

VIEW PDF 08 DEC 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) received another Notice of Allowance for a new patent covering the use of cell phones and watches to analyze movement disorders such as Parkinson’s disease. The new

App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson’s Disease: Reliability and Responsiveness

Heldman DA, Urrea-Mendoza E, Lovera LC, Schmerler DA, Garcia X, Mohammad ME, McFarlane MCU, Giuffrida JP, Espay AJ, Fernandez HH. J Parkinsons Dis. 2017;7(4):741-747.

Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment?

Vittal P, Pulliam CL, Goetz CG, Ouyang B, Jankovic J, Ramirez-Castaneda JL, Heldman, DA. Mov Disord Clin Pract. 2018; 5: 96-98.

Great Lakes NeuroTechnologies Expands Patent Portfolio

VIEW PDF 12 SEPT 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) expanded its large patent portfolio covering deep brain stimulation (DBS) tuning to 11 issued patents (and 20 currently pending applications) when it was recently awarded Patent 9,717,920

Telehealth Management of Parkinson’s Disease Using Wearable Sensors: An Exploratory Study

Dustin A. Heldman; Denzil A. Harris; Timothy Felong; Kelly L. Andrzejewski; E. Ray Dorsey; Joseph P. Giuffrida; Barry Goldberg; Michelle A. Burack. Digit Biomark 2017;1:43–51

Reliability of Continuous Parkinson’s Assessment Using Wearables

Dustin Heldman, Enrique Urrea Mendoza, Nicola Mennucci , Carol Zimmerman, Joseph Giuffrida, Zoltan Mari, Michelle Burack, Fredy J. Revilla 69th Annual Meeting of the American Academy of Neurology, Boston, MA, 2017

Telehealth Management of Parkinson’s Disease Using Wearable Sensors: An Exploratory Study

Dustin Heldman, Denzil Harris, Timothy Felong, Kelly Andrzejewski, E. Ray Dorsey, Joseph Giuffrida, Barry Goldberg, Michelle Burack 69th Annual Meeting of the American Academy of Neurology, Boston, MA, 2017

Continuous Assessment of Levodopa Response in Parkinson’s Disease Using Wearable Motion Sensors

Christopher L. Pulliam;  Dustin A. Heldman; Elizabeth B. Brokaw; Thomas O. Mera; Zoltan K. Mari; Michelle A. Burack IEEE Trans Biomed Eng. 2018 Jan;65(1):159-164.

Great Lakes NeuroTechnologies Receives Two Deep Brain Stimulation Programming Patents

VIEW PDF 21 FEB 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has recently received two Deep Brain Stimulation (DBS) tuning patents. DBS is used on patients with Parkinson’s disease and other movement disorders to help mitigate their symptoms. 

Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent

VIEW PDF 11 JAN 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has been awarded Patent 9,522,278 (Movement Disorder Therapy System and Methods of Tuning Remotely, Intelligently and/or Automatically) from the US Patent Office, the seventh patent awarded to